We only have this paper's title and publication details.
Read it at the sourceCase series evaluates daratumumab's efficacy in patients with anti-interferon-gamma autoantibodies, suggesting potential therapeutic benefits.
No takes yet. Share an insight, caveat, or question.
Tan et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: